Ampersand Biomedicines
John Bray is an experienced scientist in the biomedicine field, currently serving as an Associate Scientist at Ampersand Biomedicines since June 2022. Prior to this role, John worked as a Senior Research Associate at Sonata Therapeutics from December 2020 to June 2022 and held the position of Principal Research Associate at the University of Arizona from May 2017 to December 2020. John Bray earned a Bachelor of Science in Biochemistry from the University of Arizona, completing the degree in May 2018.
This person is not in any offices
Ampersand Biomedicines
Ampersand Biomedicines enables a new way of designing programmable medicines that work precisely where needed in the body and nowhere else. The company’s state-of-the-art computationally powered Address, Navigate, Design (AND)™ Platform continually learns the rules for identifying optimal localizer targets and refines its ability to design across the complex space of localizers and actuators. The result is increasingly sophisticated AND-Body™ therapeutics that are engineered across the physical constraints of molecules and the biological characteristics of the targets to effectively target the site of disease without affecting healthy tissue or cells. Ampersand Biomedicines was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering.